Eva M. Vasquez

735 total citations
30 papers, 552 citations indexed

About

Eva M. Vasquez is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Eva M. Vasquez has authored 30 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Transplantation, 9 papers in Pediatrics, Perinatology and Child Health and 7 papers in Surgery. Recurrent topics in Eva M. Vasquez's work include Renal Transplantation Outcomes and Treatments (17 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Transplantation: Methods and Outcomes (4 papers). Eva M. Vasquez is often cited by papers focused on Renal Transplantation Outcomes and Treatments (17 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Transplantation: Methods and Outcomes (4 papers). Eva M. Vasquez collaborates with scholars based in United States, Switzerland and Japan. Eva M. Vasquez's co-authors include Raymond Pollak, E. Benedetti, Nicole M. Sifontis, Maria Luisa Tanzi, David I. Min, Enrico Benedetti, Robert Wong, Duane G. Wombolt, Thomas Waid and Mark D. Pescovitz and has published in prestigious journals such as Transplantation, The American Journal of Surgery and British Journal of Clinical Pharmacology.

In The Last Decade

Eva M. Vasquez

28 papers receiving 521 citations

Peers

Eva M. Vasquez

TRANS

SURGE

PPCH

ONCOL

EPIDE

Timothy J. Schroeder United States

David Schladt United States

Thomas Vanhove Belgium

G. Roussey France

F. Villemain France

Neumayer Hh Germany

Eduard M. Scholten Netherlands

A.-É. Heng France

P Weiskittel United States

Louise M. Andrews Netherlands

Timothy J. Schroeder United States

Eva M. Vasquez

253 ×0.9

TRANS

143 ×1.0

SURGE

82 ×0.6

PPCH

39 ×0.5

ONCOL

42 ×0.6

EPIDE

Citations per year, relative to Eva M. Vasquez Eva M. Vasquez (= 1×) peers Timothy J. Schroeder

Countries citing papers authored by Eva M. Vasquez

Since Specialization

Citations

This map shows the geographic impact of Eva M. Vasquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva M. Vasquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva M. Vasquez more than expected).

Fields of papers citing papers by Eva M. Vasquez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva M. Vasquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva M. Vasquez. The network helps show where Eva M. Vasquez may publish in the future.

Co-authorship network of co-authors of Eva M. Vasquez

This figure shows the co-authorship network connecting the top 25 collaborators of Eva M. Vasquez. A scholar is included among the top collaborators of Eva M. Vasquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva M. Vasquez. Eva M. Vasquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vasquez, Eva M., et al.. (2020). M029 CYTOKINE RELEASE SYNDROME SECONDARY TO BENRALIZUMAB. Annals of Allergy Asthma & Immunology. 125(5). S62–S62.

Shord, Stacy S., Lingtak‐Neander Chan, Eva M. Vasquez, et al.. (2009). Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam. British Journal of Clinical Pharmacology. 69(2). 160–166. 23 indexed citations

Vasquez, Eva M., et al.. (2005). Concomitant Clotrimazole Therapy More Than Doubles the Relative Oral Bioavailability of Tacrolimus. Therapeutic Drug Monitoring. 27(5). 587–591. 14 indexed citations

Vasquez, Eva M., et al.. (2005). An assessment of P-glycoprotein expression and activity in peripheral blood lymphocytes of transplant candidates. Transplantation Proceedings. 37(1). 175–177. 17 indexed citations

Vasquez, Eva M., et al.. (2004). SIMVASTATIN FOR PREVENTION OF BONE LOSS FOLLOWING RENAL TRANSPLANTATION. Transplantation. 78. 293–293. 3 indexed citations

Sifontis, Nicole M., E. Benedetti, & Eva M. Vasquez. (2002). Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients. Transplantation Proceedings. 34(5). 1730–1732. 36 indexed citations

Vasquez, Eva M., Enrico Benedetti, & Raymond Pollak. (2001). ETHNIC DIFFERENCES IN CLINICAL RESPONSE TO CORTICOSTEROID TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION. Transplantation. 71(2). 229–233. 13 indexed citations

Benedetti, Enrico, et al.. (2001). Successful simultaneous pancreas-kidney transplantation from well-matched living-related donors. Transplantation Proceedings. 33(1-2). 1689–1689. 1 indexed citations

Vasquez, Eva M., et al.. (2000). PRN2: COST-EFFECTIVENESS OF BASILIXIMAB, DACLIZUMAB, AND OKT3 AS INDUCTION AGENTS IN KIDNEY TRANSPLANTATION. Value in Health. 3(2). 140–140. 2 indexed citations

10.

Vasquez, Eva M., Enrico Benedetti, & Raymond Pollak. (1998). Late Acute Rejection is More Prevalent Among African-American Renal Allograft Recipients and is Frequently Associated With Allograft Loss. Transplantation Proceedings. 30(4). 1173–1175. 9 indexed citations

11.

Benedetti, Enrico, et al.. (1998). Value of Perioperative Treatment With Sandostatin After Pancreas Transplantation: A Prospective Randomized Trial. Transplantation Proceedings. 30(2). 432–433. 1 indexed citations

12.

Benedetti, Enrico, Massimo Asolati, Ty B. Dunn, et al.. (1998). A Prospective Randomized Clinical Trial of Perioperative Treatment with Octreotide in Pancreas Transplantation. The American Journal of Surgery. 175(1). 14–17. 22 indexed citations

13.

Pescovitz, Mark D., Gary W. Barone, Miles G. Choc, et al.. (1997). SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION VERSUS CYCLOSPORINE: TWO-YEAR DATA IN PRIMARY RENAL ALLOGRAFT RECIPIENTS. Transplantation. 63(5). 778–780. 18 indexed citations

14.

Vasquez, Eva M., et al.. (1996). Antibody‐mediated hemolytic anemia following ABO‐mismatched organ transplantation: contributory role of HLA matching and polyclonal antilymphocyte globulin. Clinical Transplantation. 10(2). 166–169. 10 indexed citations

15.

Vasquez, Eva M. & Raymond Pollak. (1996). EFFECT OF PRETRANSPLANT ERYTHROPOIETIN THERAPY ON RENAL ALLOGRAFT OUTCOME. Transplantation. 62(7). 1026–1028. 6 indexed citations

16.

Barone, Gary W., C. Martin Bunke, Miles G. Choc, et al.. (1996). THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1. Transplantation. 61(6). 968–970. 35 indexed citations

17.

Barone, Gary W., Miles G. Choc, Jon B. Klein, et al.. (1996). THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1. Transplantation. 61(6). 875–880. 82 indexed citations

18.

Vasquez, Eva M. & Raymond Pollak. (1996). Effect of oral pentoxyfylline on the OKT3‐induced cytokine‐release syndrome among renal allograft recipients. Clinical Transplantation. 10(3). 294–297. 3 indexed citations

19.

Vasquez, Eva M., Alfredo J. Fabrega, & Raymond Pollak. (1995). OKT3-induced cytokine-release syndrome: occurrence beyond the second dose and association with rejection severity.. PubMed. 27(1). 873–4. 11 indexed citations

20.

Vasquez, Eva M., et al.. (1993). HIGH-DOSE ORAL ACYCLOVIR PROPHYLAXIS FOR PRIMARY CYTOMEGALOVIRUS INFECTION IN SERONEGATIVE RENAL ALLOGRAFT RECIPIENTS. Transplantation. 55(2). 448–449. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact